Conditionally cleavable radioimmunoconjugates: A novel approach for the release of radioisotopes from radioimmunoconjugates

Bioconjugate Chemistry

Volumn 14, Issue 5, 2003, Pages 927-933

  Beeson, Craig ^b,e   Butrynski, James E ^a   Hart, Michael J ^b   Nourigat, Cynthia ^a   Matthews, Dana C ^a,c   Press, Oliver W ^a   Senter, Peter D ^d   Bernstein, Irwin D ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SEATTLE GENETICS INC   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; ENZYMES; MAMMALS; MONOCLONAL ANTIBODIES; TUMORS;

BIODISTRIBUTIONS; ENZYME TREATMENT; HUMAN TUMORS; IN-VIVO; RADIATION EXPOSURE; RADIOIMMUNOCONJUGATES; RADIOLABEL; TUMOUR XENOGRAFTS; VIVO STUDIES; Β-LACTAMASE;

RADIOISOTOPES;

ANTIBODY CONJUGATE; BETA LACTAMASE; CD20 ANTIGEN; CEPHALOSPORIN; IODINE 131; MONOCLONAL ANTIBODY; RADIOIMMUNOCONJUGATE; RADIOISOTOPE; TOSITUMOMAB I 131; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME THERAPY; HUMAN; HUMAN CELL; ISOTOPE LABELING; RADIATION EXPOSURE; TUMOR XENOGRAFT;

EID: 0141569732     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025655z     Document Type: Article

References (22)

1. Goodwin, D. A., and Meares, C. F. (1999) Pretargeted peptide imaging and therapy. Cancer Biother. Radiopharm. 14, 145-152.
2. Goodwin, D. A., and Meares, C. F. (1997) Pretargeting: general principles. Cancer 80 (Suppl.), 2675-2680.
3. Press, O. W., Corcoran, M., Subbiah, K., Hamlin, D. K., Wilbur, D. S., Johnson, T., Theodore, L., Yau, E., Mallett, R., Meyer, D. L., and Axworthy, D. A. (2001) Comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts. Blood 98, 2535-2543.
4. Hamblett, K. J., Kegley, B., Hamlin, D., Chyan, M., Hyre, D., Press, O., Wilbur, D., and Stayton, P. (2002) A streptavidin-biotin binding system that minimizes blocking by endogenous biotin. Bioconjugate Chem. 13, 588-598.
5. DeNardo, G. L., Maddock, S. W., Sgouros, G., Scheibe, P. O., and DeNardo, S. J. (1993) Immunoadsorption: an enhancement strategy for radioimmunotherapy. J. Nucl. Med. 34, 1020-1027.
6. Sgouros, G. (1992) Plasmapheresis in radioimmunotherapy of micro-metastases: a mathematical modeling and dosimetrical analysis. J. Nucl. Med. 33, 2167-2179.
7. Norrgren, K., Strand, S. E., and Ingvar, C. (1992) Contrast enhancement in RII and modification of the therapeutic ratio in RIT: A theoretical evaluation of simulated extracorporeal immunoadsorption. Antibody Immunoconjugate Radiopharm. 3, 61-73.
8. Chen, J. Q., Strand, S. E., Tennvall, J., Lindgren, L., Hindorf, C., and Sjogren, H. O. (1997) Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated Rhenium-188-chimeric BR96. J. Nucl. Med. 38, 1934-1939.
9. Dienhart, D. G., Kasliwal, R., and Lear, J. L. (1994) Extracorporeal immunoadsorption of radiolabeled monoclonal antibody: a method for reduction of background radioactivity and its potential role during the radioimmunotherapy of cancer. Antibody Immunoconj. Radiopharm. 7, 225-252.
10. Marshall, D., Pedley, R. B., Boden, J. A., Boden, R., and Begent, R. H. (1994) Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model. Br. J. Cancer 69, 502-507.
11. Kobayashi, H., Sakahara, H., Hosono, M., Yao, Z. S., Toyama, S., Endo, K., and Konishi, J. (1994) Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J. Nucl. Med. 35, 1677-1684.
12. Studer, M., Kroger, L. A., DeNardo, S. J., Kukis, D. L., and Meares, C. F. (1992) Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA: Comparison of enzymatic digestion in vitro and in vivo. Bioconjugate Chem. 3, 424-429.
13. Stein, R., Goldenberg, D. M., Ong, G. L., Thorpe, S. R., and Mattes, M. J. (1997) Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivo. J. Nucl. Med. 38, 1392-1400.
14. DeNardo, G. L., Kroger, L. A., Meares, C. F., Richman, C. M., Salako, Q., Shen, S., Lamborn, K. R., Peterson, J. J., Miers, L. A., Zhong, G. R., and DeNardo, S. J. (1998) Comparison of 1,4,7,10-tetraazacyclododecane-n,n′ ,n″,n‴-tetraacetic acid (DOTA)-peptide-CHL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-CHL6 in breast cancer xenografts. Clin. Cancer Res. 4, 2483-2490.
15. Arano, Y., Wakisaka, K., Akizawa, H., Ono, M., Kawai, K., Nakayama, M., Sakahara, H., Konishi, J., and Saji, H. (1998) Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery. Bioconjugate Chem. 9, 497-506.
16. Smith, L. I., and Howard, K. L. (1955) Preparation of diphenyldiazomethane. Organic Syntheses; Collect. Vol. III, p 351, Wiley, New York.
17. Cartwright, S. J., and Waley, S. G. (1984) Purification of beta-lactamases by affinity chromatography on phenylboronic acid-agarose. Biochem. J. 221, 505-512.
18. Shannon, K., and Phillips, I. (1980) Beta-lactamase detection by three simple methods: intralactam, nitrocefin and acidimetric. J. Antimicrob. Chemother. 6, 617-621.
19. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A., Jr. (1984) Determination of the immunoreactive fraction of labeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods 72, 77-89.
20. Melton, R. G., and Sherwood, R. F. (1996) Antibody-enzyme conjugates for cancer therapy. J. Natl. Cancer Inst. 88, 153-165.
21. Syrigos, K. N., and Epenetos, A. A. (1999) Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations. Anticancer Res. 19, 605-613.
22. Mikolajcyzk, S. D., Meyer, D. L., Fagnani, R., Hagan, M. S., Law, K. L., and Starling, J. J. (1996) Dextran modification of a Fab′-β -lactamase conjugate modulated by variable pretreatment of Fabκ with amine-blocking reagents. Bioconjugate Chem. 7, 150-158.